Dr. Hönle AG

Hönle Increases Operating Result by 26 %

@@start.t1@@--------------------------------------------------------------------------------   ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for   the content of this announcement. --------------------------------------------------------------------------------@@end@@

balance

Gräfeling/München (euro adhoc) - According to preliminary figures, revenue and operating result of the UV specialist, Dr. Hönle AG (ISIN: DE0005157101), saw significant increase in financial year 2006/2007. Revenues earned by the Hönle Group rose by 10.8 % to TEUR 26,246 in comparison with the prior year period. The earnings before interest and taxes (EBIT) climbed 26.6 % to TEUR 4,339, and the pre-tax result (EBT) by 23.0 % to TEUR 4,967. Consolidated net income improved by 7.8 % to TEUR 3,013, and net profit on sales was 11.5 % in the financial year ended after being 11.8 % in the previous year.

Dr. Hönle AG´s Management Board and Supervisory Board will propose to the General Meeting that a dividend of EUR 0.40 per share be paid from Dr. Hönle AG´s unappropriated retained earnings.

The liquid assets, securities and own shares inventory increased further from TEUR 19,085 in the previous year to TEUR 20,320 in financial year 2006/2007. This represents a value of EUR 3.69 per share.

All company segments contributed to the increase in revenues. The positive development is mainly due to the expansion of distribution capacities last year, which led to a considerably stronger market presence in all relevant target markets. Moreover, new market segments in the printing industry were opened up as a result of these measures.

Outlook: The Hönle Group intends to further expand its strong market position that it has achieved and will further strengthen its sales team in the new financial year. R&D capacities will also be further extended to increase competitiveness. Strategically important growth segments such as digital printing will see targeted promotion through increased research and development activities. Hönle´s activities will also be focused on direct access to the sheet-fed offset printing market and expansion of activities in the rotary offset printing market. In all, the Company expects favourable general conditions and opportunities for positive development. In combination with the recently reported Panacol Group acquisition, the Hönle Group expects significant revenue and earnings growth in the coming years as well.

The Annual Report will be published on 18 January 2008 as scheduled.

@@start.t2@@end of announcement                                                 euro adhoc
--------------------------------------------------------------------------------@@end@@

ots Originaltext: Dr. Hönle AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Contact: Dr. Hönle AG, Peter Weinert, Lochhamer Schlag 1, 82166
Graefelfing/Munich, Tel.: 0049-89-85608-173, Fax: 0049-89-85608-101,
ir@hoenle.de, www.hoenle.de

Branche: Instrument Engineering
ISIN:      DE0005157101
WKN:        515710
Index:    CDAX, Prime All Share, Technologie All Share
Börsen:  Börse Frankfurt / regulated dealing/prime standard
              Börse Berlin / free trade
              Börse Hamburg / free trade
              Börse Stuttgart / free trade
              Börse Düsseldorf / free trade
              Börse Hannover / free trade
              Börse München / free trade



Weitere Meldungen: Dr. Hönle AG

Das könnte Sie auch interessieren: